New NCI Grant to Foster Development of Novel Therapy in Metastatic Colorectal Cancer
Conexiant
May 2, 2024
Case Western Reserve University received a 5-year $1.84 million NCI grant to study LRG1 protein in metastatic colorectal cancer.
The research aims to understand how LRG1 secretion from the liver contributes to colorectal cancer metastasis.
Patients with liver metastases typically show poorer treatment responses, highlighting the need for new therapies.
The study will explore mechanisms of cancer cell proliferation to inhibit tumor growth effectively.
Preliminary data indicates that using antibodies may block communication between liver and colorectal cancer cells.
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
News Staff
Affiliations:
Specialties:
Areas of Expertise: